… had a dose reduction showed that efficacy was maintained in patients who had … gefitinib
in the Asian population of ARCHER 1050 [15]. This report describes an analysis of the efficacy …

… Therefore, we analyzed the efficacy of these … EGFR mutations in EGFR mutation-positive
NSCLC has potential clinical implications since different EGFR TKIs have varying effectiveness …

… Gefitinib trial tumors was conducted to compare efficacy of gefitinib with that of placebo
according to EGFR … adenocarcinoma in which EGFR mutation and KRAS mutation, respectively, …

… of gefitinib to chemotherapy exists regarding the postoperative adjuvant therapy of EGFR
mutation… study to assess the efficacy of adjuvant gefitinib versus adjuvant chemotherapy (AC) in …

… efficacy in patients treated with gefitinib. The research was designed to evaluate the efficacy
and safety of pemetrexed combined with gefitinib as … harboring a sensitive EGFR mutation. …

… As a result, the use of PPIs in patients with advanced NSCLC with activating EGFR
mutations is unlikely to impact dacomitinib or gefitinib treatment efficacy despite decreased …

… NSCLC harboring EGFR mutation. Regarding the efficacy of EGFR-TKI, we previously
reported the association between smoking status and efficacy of EGFR-TKI including gefitinib and …

… EGFR mutations … EGFR-TKIs in EGFR mutated LSCC patients. In this study, we performed
a pooled analysis to evaluate the efficacy of EGFR-TKIs in LSCC patients with EGFR mutations…

… The efficacy of EGFR-TKIs has been shown to be associated with the EGFR mutation
status, especially exon 19 deletion (19Del) and exon 21 L858R mutation. Therefore, a meta-…

… S768I mutation received first- and second-generation EGFR-TKIs successively, and the
response was completely different. The S768I mutation is a rare subset of EGFR mutants located …